SARS-CoV-2-Infection (COVID-19): Clinical Course, Viral Acute Respiratory Distress Syndrome (ARDS) and Cause(s) of Death
- PMID: 36278528
- PMCID: PMC9590085
- DOI: 10.3390/medsci10040058
SARS-CoV-2-Infection (COVID-19): Clinical Course, Viral Acute Respiratory Distress Syndrome (ARDS) and Cause(s) of Death
Abstract
SARS-CoV-2-infected symptomatic patients often suffer from high fever and loss of appetite which are responsible for the deficit of fluids and of protein intake. Many patients admitted to the emergency room are, therefore, hypovolemic and hypoproteinemic and often suffer from respiratory distress accompanied by ground glass opacities in the CT scan of the lungs. Ischemic damage in the lung capillaries is responsible for the microscopic hallmark, diffuse alveolar damage (DAD) characterized by hyaline membrane formation, fluid invasion of the alveoli, and progressive arrest of blood flow in the pulmonary vessels. The consequences are progressive congestion, increase in lung weight, and progressive hypoxia (progressive severity of ARDS). Sequestration of blood in the lungs worsens hypovolemia and ischemia in different organs. This is most probably responsible for the recruitment of inflammatory cells into the ischemic peripheral tissues, the release of acute-phase mediators, and for the persistence of elevated serum levels of positive acute-phase markers and of hypoalbuminemia. Autopsy studies have been performed mostly in patients who died in the ICU after SARS-CoV-2 infection because of progressive acute respiratory distress syndrome (ARDS). In the death certification charts, after respiratory insufficiency, hypovolemic heart failure should be mentioned as the main cause of death.
Keywords: SARS-CoV-2 infection; acute respiratory distress syndrome; cause of death; dehydration; diffuse alveolar damage (DAD); heart failure; hyaline membrane; hypoalbuminemia; lung weight; pulmonary engorgement; pulmonary hypoxia.
Conflict of interest statement
The author declares no conflict of interest.
Figures


Similar articles
-
Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19.J Biomol Struct Dyn. 2021 Oct;39(17):6842-6851. doi: 10.1080/07391102.2020.1803139. Epub 2020 Aug 5. J Biomol Struct Dyn. 2021. PMID: 32752936 Free PMC article. Review.
-
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16. Am J Emerg Med. 2021. PMID: 33046317 Free PMC article.
-
COVID-19-Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells.Crit Care Clin. 2021 Oct;37(4):777-793. doi: 10.1016/j.ccc.2021.05.004. Epub 2021 May 26. Crit Care Clin. 2021. PMID: 34548133 Free PMC article. Review.
-
Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome.Am J Respir Crit Care Med. 2022 Oct 1;206(7):857-873. doi: 10.1164/rccm.202109-2150OC. Am J Respir Crit Care Med. 2022. PMID: 35671465 Free PMC article.
-
Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.EBioMedicine. 2020 Jul;57:102833. doi: 10.1016/j.ebiom.2020.102833. Epub 2020 Jun 20. EBioMedicine. 2020. PMID: 32574956 Free PMC article.
Cited by
-
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors.Curr Issues Mol Biol. 2023 Jan 4;45(1):400-433. doi: 10.3390/cimb45010028. Curr Issues Mol Biol. 2023. PMID: 36661514 Free PMC article. Review.
-
SARS-CoV-2 infection of polarized human airway epithelium induces necroptosis that causes airway epithelial barrier dysfunction.J Med Virol. 2023 Sep;95(9):e29076. doi: 10.1002/jmv.29076. J Med Virol. 2023. PMID: 37671751 Free PMC article.
-
Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator.Front Pharmacol. 2024 Feb 7;15:1303342. doi: 10.3389/fphar.2024.1303342. eCollection 2024. Front Pharmacol. 2024. PMID: 38384295 Free PMC article.
-
Effects of Smoking on COVID-19 Management and Mortality: An Umbrella Review.J Smok Cessat. 2023 May 13;2023:7656135. doi: 10.1155/2023/7656135. eCollection 2023. J Smok Cessat. 2023. PMID: 37214631 Free PMC article. Review.
-
SARS-CoV-2 Pneumonia: Advances in Diagnosis and Treatment.Microorganisms. 2025 Jul 31;13(8):1791. doi: 10.3390/microorganisms13081791. Microorganisms. 2025. PMID: 40871295 Free PMC article. Review.
References
-
- World Health Organization (WHO) COVID-19 Weekly Epidemiological Update. World Health Organization (WHO); Geneva, Switzerland: 2022.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous